CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cynata Therapeutics Ltd Company Snapshot
Cynata Therapeutics Limited is a stem cell and regenerative medicine company. The Company is engaged in the development and commercialization of a mesenchymal stem cell (MSC) technology for human therapeutic use, Cymerus. Its Cymerus technology facilitates manufacture of MSCs from a single donor and a single donation. The Company's Cymerus platform stem cell technology is based upon stem cells known as mesenchymoangioblasts (MCAs). The Company's technology utilizes induced pluripotent stem cells (iPSCs) originating from an adult donor as the starting material for generating MCAs and in turn for manufacturing the MSC therapeutic product. The Cymerus platform provides a source of MSCs that is independent of donor limitations and provides an off-the-shelf stem cell platform for therapeutic product use. The Company's MSCs produced using Cymerus technology, can be used to treat unrelated patients, without any need to match the recipient to the donor.

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cynata Therapeutics Ltd
  Stock Performance Chart for Cynata Therapeutics Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): .70
(Figures in Australian Dollars)
1 Week 8.5%   13 Weeks 0.0%  
4 Weeks 12.9%   52 Weeks 27.3%  
 
Cynata Therapeutics Ltd Key Data:
  Ticker: CYP Country: Australia
  Exchanges: Major Industry: Consumer Durables & Apparel
    Sub Industry: Nonwoven Fabrics
  2017 Sales 94,231
(Year Ending Jan 2018).
Employees: N/A
  Currency: Australian Dollars Market Cap: 63,040,074
  Fiscal Yr Ends: June Shares Outstanding: 90,057,248
  Share Type: Units Closely Held Shares: 23,341,995
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.